Both in Pharmaceuticals
Omeros vs Nektar Therapeutics
Over the past year OMER returned +145.2% and NKTR returned −38.1%; their daily moves had a correlation of 0.16.
OMER +145.2% NKTR −38.1%Growth of $1, one year, split-adjusted
| Metric | OMER | NKTR |
|---|---|---|
| Price | $18.44 | $38.87 |
| Market cap | $1.33B | $1.33B |
| Today | −2.69% | −0.79% |
| 1 month | −0.2% | −17.3% |
| 6 months | +22.4% | −55.0% |
| Year to date | +7.4% | −8.1% |
| 1 year | +140.1% | −34.8% |
| Revenue growth (YoY) | — | −9.3% |
| Gross margin | 97.2% | 100.0% |
| Net margin | 46.4% | −401.0% |
| P/E (TTM) | 10.7× | — |
| Price / sales | 34.7× | 24.3× |
| Net cash | $58.7M | $684.3M |
| Dividend yield | — | — |
| Volatility (60d) | 76.3% | 69.9% |
| Short % of float | 17.8% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).